Nanohmics Inc.

Nanohmics Inc., an Austin, Texas-based for-profit small business, operates as a pure prime contractor delivering advanced research and development in electronics, optics, sensors, imaging systems, and thermal management across 23 years and 333 federal awards—99% as prime with negligible subcontractor activity—competing predominantly under total small business and SBIR/STTR set-asides across defense and civilian federal agencies.

The vendor's portfolio spans Phase I and Phase II SBIR and STTR contracts together with direct R&D awards in physical, engineering, and life sciences. Representative work includes a $1.975 million Marine Corps SBIR Phase II for multi-color long-wave infrared imagers, a $1.5 million Office of the Secretary of Defense contract for inversely-designed dispersion-engineered electrically small antennas, a $1.441 million Missile Defense Agency STTR Phase II for conformal and compact tri-band antenna development, and a $1.315 million Army RDECOM contract for millimeter-wave imaging with high-electron-mobility transistors. Recent Phase I efforts span quantum-engineered multispectral array platforms for trace neutral-gas monitoring ($224,997 Shared Services Center, September 2026), microchip laser-integrated 2D entangled photon sources ($900,000 Shared Services Center, July 2026), and volume-constrained additive-manufactured polymers for integrated robust electronics—the VAMPIRE project ($900,000 Shared Services Center, June 2026). Nanohmics holds a multi-billion-dollar ceiling IDIQ under the Missile Defense Agency's Scalable Homeland Innovative Enterprise Layered Defense (SHIELD) vehicle, awarded December 29, 2025, with place of performance at Huntsville, Alabama, running through December 28, 2035; the initial $500 delivery order was issued the same date.

Customer concentration clusters in defense and civilian R&D communities. The top five agencies by award count account for 47% of all awards: the Air Force Research Laboratory (58 awards, $18.9 million combined potential value), NASA Shared Services Center (42 awards, $12.3 million), Army RDECOM (22 awards, $10.1 million), Army Medical Command (20 awards, $5.5 million), and Office of Naval Research (14 awards, $6.7 million). When ranked by potential value, the Defense Health Agency rises to third place ($11.8 million across 6 awards), reflecting larger contract vehicles in medical device and physiological monitoring research. Together, these five agencies represent 51% of combined potential value across the portfolio.

Activity has contracted year over year—31 awards in 2022 to 9 in 2026 year-to-date—with 16 awards carrying combined potential value of $12.5 million reaching ultimate completion inside the next twenty-four months and facing recompete. The SCI dataset shows $3.5 million in invoiced federal services revenue across FY2022 through FY2025, with peak activity in FY2023 ($2.9 million invoiced across 7.6 FTEs). Government-paid hourly rates on federal services contracts, derived from invoiced dollars and contractor hours, ran a median of $204.15 per hour, with a range from a 10th percentile of $141.75 per hour through a 90th percentile of $371.48 per hour. SCI captures only service contracts above the $150,000 threshold; Nanohmics' federal revenue footprint is substantially larger when goods, products, and unclassified R&D awards are included. Across SCI-reportable prime contracts, the vendor self-performed all contractor hours with no subcontractor engagement.

In its sub-contractor role, Nanohmics delivered a critical-design MLACES review component under a BAE Systems Information & Electronic Systems Integration Inc. prime on July 23, 2026. As a federal grant recipient, Nanohmics acts as prime awardee on multi-agency technology development efforts: the Centers for Disease Control and Prevention (CFDA 93.283) awarded $1.825 million on September 30, 2025, for lateral flow-electrochemiluminescent test strips and a portable reader for ultrasensitive foodborne pathogen detection; the National Institute of Environmental Health Sciences (CFDA 93.113) awarded $313,365 on August 1, 2026, for a handheld fluorescent lysosomal yeast biosensor for toxic metal ions and organic pollutants in water; the Department of Energy Office of Science (CFDA 81.049) awarded $206,496 on July 22, 2024, for thermoelectric ocean energy harvesters for maritime sensors; and the National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a project grant on September 23, 2022, for an ambulatory cryocooling therapy device. The company also received project grants from the Food and Drug Administration (CFDA 93.103) and the National Center for Advancing Translational Sciences (CFDA 93.350) for portable optical imagers and lateral flow-electrochemiluminescent platforms targeting foodborne pathogen detection. Nanohmics sub-receives grant work under Rice University's Center for Advanced Space Sensing Technologies initiative (June 2026). The vendor's grant portfolio signals diversification into health, food safety, and energy domains alongside its dominant defense R&D posture.